drugset / Trial / NCT06569537

Comparison of Compounded Topical Anesthetics

NCT06569537

Phase 4 Completed 63 enrolled Dartmouth-Hitchcock Medical Center
RandomizedParallel-groupQuadruple-blindSupportive care

Summary

The primary objective for this pilot study is to evaluate the efficacy of the compounded topical anesthetic Benzocaine 20%/ Lidocaine 8%/Tetracaine 4% (BLT) compared to 4% Lidocaine topical in providing relief of pain during IPL, PDL, and microneedling procedures.

Timeline

Start
2024-10-22
Primary completion
2025-12-19
Completion
2025-12-19

Drugs

EvaluationDrugModalityDoseRoute
Subject BLT Unknown Topical
Subject Benzocaine Small molecule 20 % Topical
Subject Lidocaine Other / unclassified 4 % Topical
Subject Lidocaine Other / unclassified 8 % Topical
Subject tetracaine Other / unclassified 4 % Topical

Indications

No indication recorded.